Anxiety Disorders Course is organized by NetCE.
Release Date: 05/01/2019
Expiration Date: 04/30/2022
This course is designed for health and mental health providers involved in the identification, treatment, and care of patients with anxiety disorder.
This activity was planned by and for the healthcare team, and learners will receive 15 Interprofessional Continuing Education (IPCE) credit(s) for learning and change.
NetCE designates this continuing education activity for 15 ANCC contact hour(s). NetCE designates this continuing education activity for 12 pharmacotherapeutic/pharmacology contact hour(s). NetCE designates this continuing education activity for 18 hours for Alabama nurses. AACN Synergy CERP Category A.
Education Category: Psychiatric / Mental Health
Anxiety disorders are characterized by states of chronic, excessive dread or fear of everyday situations. The fear and avoidance can be life-impairing and disabling. Anxiety disorders result from the interaction of biopsychosocial factors, whereby genetic vulnerability interacts with situations, stress, or trauma to produce clinically significant syndromes. The influence from hereditary factors and adverse psychosocial experiences on anxiety disorder pathogenesis and pathophysiology is complex, but neuroscience advances have greatly improved the understanding of the underlying factors in the development and maintenance of anxiety disorders.
The purpose of this course is to provide healthcare professionals with the knowledge and skills necessary to appropriately identify and treat patients with anxiety disorders, addressing knowledge gaps, enhancing clinical skills, and improving patient outcomes.
Upon completion of this course, you should be able to:
• Review basic concepts related to anxiety disorders, including safety behaviors/signals and primary features.
• Outline the epidemiology of anxiety disorders in the United States.
• Describe general risk factors for and comorbidities of anxiety disorders.
• Describe risk factors for and the clinical course of specific anxiety disorders.
• Discuss the pathogenesis of anxiety disorders in relation to contributing genetic, physiologic, and psychologic factors.
• Review the pathophysiology of specific anxiety disorders, including social anxiety disorder, agoraphobia, and specific phobia.
• Evaluate the clinical and diagnostic criteria for anxiety disorders presented in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5).
• Analyze key components of screening for anxiety disorders.
• List conditions to consider in the differential diagnosis of anxiety disorders.
• Describe general treatment considerations for anxiety disorders, including predictors of response or nonresponse to therapy.
• Discuss the role of various psychotherapy approaches in the treatment of anxiety disorders.
• Outline pharmacotherapy options for the treatment of anxiety disorders.
• Recognize clinical issues related to the treatment of anxiety disorders.
• Compare and contrast the treatment recommendations for specific anxiety disorders.
• Analyze the evidence base supporting the efficacy of novel, emerging, and alternative/complementary approaches to the treatment of anxiety disorders.
Psychiatry, Clinical Psychology